A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor ('SPROG' trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN

R. C. F. Leonard, J. L. Mansi (Lead / Corresponding author), C. Keerie, A. Yellowlees, S. Crawford, K. Benstead, R. Matthew, D. Adamson, S. Chan, R. Grieve, on behalf of the Anglo-Celtic Collaborative Oncology Group

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor ('SPROG' trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN'. Together they form a unique fingerprint.

    Medicine & Life Sciences